Benzinga | Aug 6, 2020 09:10AM EDT

Anavex Life Sciences Earlier Reported Q3 EPS $(0.11) Beats $(0.14) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.14) per share from the same period last year.